Targeted Therapies
Nordion supplies targeted therapies for a variety of cancers, which are focused on targeting the disease from within the body with a higher concentration of radiation directed to the tumour, thereby minimizing both damage to surrounding healthy tissue and unpleasant side effects. Using our world-class expertise and capabilities, Nordion also offers services for radiopharmaceutical development, and clinical and commercial manufacturing.
Nordion's main targeted therapies product is TheraSphere®, which is used in the treatment of inoperable liver cancer. Nordion is also a contract manufacturer for Bexxar®, a radiotherapeutic and CardioGen-82™, a cardiovascular positron emission tomography (PET) imaging agent.
Products & Services
VIDEO: TheraSphere Animation
More About TheraSphere: An Innovative Treatment for Liver Cancer
